Official registry condition

Hyperparathyroidism, Secondary peptide trials

7 selected ClinicalTrials.gov records carrying the official condition label Hyperparathyroidism, Secondary. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

7 selected records.

Connected peptides

1 profiles.

Registry update years

2017–2019 in selected records.

Indication intelligence

Selected evidence landscape

Connected profiles1

Exact peptide identities attached to retained registry observations carrying this condition label.

Trial phases2

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses1

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 28 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Hyperparathyroidism, Secondary unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT01134549

PeptideScanner retained ClinicalTrials.gov record NCT01134549 at 2026-11-15T22:07:29.454Z. Its registry update date was 2017-04-14, and PeptideScanner's reviewed identity mapping was etelcalcetide.

PeptideScanner change date
November 15, 2026
Cited source date
April 14, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01134562

PeptideScanner retained ClinicalTrials.gov record NCT01134562 at 2026-11-15T22:07:29.454Z. Its registry update date was 2018-01-02, and PeptideScanner's reviewed identity mapping was etelcalcetide.

PeptideScanner change date
November 15, 2026
Cited source date
January 2, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01785849

PeptideScanner retained ClinicalTrials.gov record NCT01785849 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-08-26, and PeptideScanner's reviewed identity mapping was etelcalcetide.

PeptideScanner change date
November 15, 2026
Cited source date
August 26, 2019
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →